Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. |
2020-11-02 |
EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. |
2020-11-02 |
EBD Group. (10/28/20). "Press Release: BIO-Europe Digital Startup Slam Winner 2020 – KyNexis Medicine Development". Munich. |
2020-10-28 |
Galecto, Inc.. (10/28/20). "Press Release: Galecto Announces Pricing of Initial Public Offering". Boston, MA & Copenhagen. |
2020-10-28 |
Eagle Genomics Ltd.. (10/27/20). "Press Release: Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend". Cambridge. |
2020-10-27 |
Gilead Sciences, Inc.. (10/23/20). "Press Release: Gilead Sciences Completes Acquisition of Immunomedics, Inc.". Foster City, CA. |
2020-10-23 |
Araris Biotech AG. (10/22/20). "Press Release: Araris Biotech Completes CHF 15.2 Million Seed Financing Round". Zürich. |
2020-10-22 |
Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. |
2020-10-20 |
ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. |
2020-10-20 |
Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium. |
2020-10-20 |
Immunic, Inc.. (10/20/20). "Press Release: EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy". Luxembourg, Gräfeling & New York, NY. |
2020-10-20 |
Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing". Hamburg. |
2020-10-19 |
Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. |
2020-10-15 |
Oncopeptides AB. (10/14/20). "Press Release: Oncopeptides Signs € 40 Million Loan Agreement with the EIB". Stockholm. |
2020-10-14 |
Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. |
2020-10-13 |
Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY. |
2020-10-13 |
Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. |
2020-10-13 |
Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt. |
2020-10-06 |
Ynsect S.A.S.. (10/6/20). "Press Release: Agtech Startup Ÿnsect Extends Its Series C to $372 Million to Improve Global Food Security and Sustainability with the First Carbon Negative and Largest Vertical Farm in the World". Paris. |
2020-10-06 |
Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent. |
2020-10-06 |
Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen. |
2020-10-06 |
Federation Bio. (10/6/20). "Press Release: Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies". South San Francisco, CA. |
2020-10-06 |
Bone Therapeutics S.A.. (10/5/20). "Press Release: Bone Therapeutics, Link Health and Pregene to Develop and Commercialize the ALLOB Allogeneic Bone Cell Therapy Platform in China and Southeast Asia". Gosselies. |
2020-10-05 |
Qiagen N.V.. (10/5/20). "Press Release: Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit that Simplifies and Accelerates PCR Analysis for Research Applications". Hilden & Germantown, MD. |
2020-10-05 |
Centre for Research on Multinational Corporations (SOMO). (10/2/20). "Press Release: New Research Reveals Large-scale Tax Avoidance by Coronavirus Test Manufacturer Qiagen". |
2020-10-02 |
Kaleido Biosciences, Inc.. (10/1/20). "Press Release: Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer". Lexington, MA. |
2020-10-01 |
ECBF Management GmbH. (10/1/20). "Press Release: New European Circular Bioeconomy Fund Is Ready to Invest in Europe's Transition to a more Sustainable Economy". Bonn. |
2020-10-01 |
Biocartis Group N.V.. (9/30/20). "Press Release: Biocartis Receives EUR 1.2 Million Grant for Development of Highly Innovative Idylla GeneFusion Assay". Mechelen. |
2020-09-30 |
NanoSyrinx Ltd.. (9/30/20). "Press Release: Synthetic Biology Start Up NanoSyrinx Secures Capital to Develop Its Fully Customisable Platform for Intra-cellular Engineering". Coventry. |
2020-09-30 |
Immatics N.V.. (9/29/20). "Press Release: Immatics Appoints Arnd Christ as Chief Financial Officer". Tübingen & Houston, TX. |
2020-09-29 |
Mosa Meat B.V.. (9/25/20). "Press Release: Mosa Meat Raises Series B Funding to Prepare for Large-scale Cultured Meat Production". Maastricht. |
2020-09-25 |
BB Pureos Bioventures. (9/23/20). "Press Release: Pureos Bioventures Closes First Fund with USD 170 Million". St. Peter Port, Guernsey & Küsnacht. |
2020-09-23 |
Salvia BioElectronics B.V.. (9/22/20). "Press Release: Salvia BioElectronics Raises EUR 26M (USD 31M) to Develop Innovative Neurostimulation Therapy for Chronic Migraine". Eindhoven. |
2020-09-22 |
Sundew ApS. (9/22/20). "Press Release: Sundew Raises €1.4m in Seed Financing. Supports Development of First Aquatic Disease Platform and Product". |
2020-09-22 |
T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. |
2020-09-21 |
Glycotope GmbH. (9/21/20). "Press Release: DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms". Leiden & Berlin. |
2020-09-21 |
InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. |
2020-09-17 |
Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. |
2020-09-17 |
Freshfields Brukhaus Deringer. (9/17/20). "Press Release: Freshfields Advises Univercells in Two Successive Equity Raising and Financing". |
2020-09-17 |
Lava Therapeutics B.V.. (9/17/20). "Press Release: Lava Therapeutics Announces $83 Million Series C Financing to Advance Novel Immuno-Oncology Programs". Utrecht & Philadelphia, PA. |
2020-09-17 |
Novo Holdings A/S. (9/17/20). "Press Release: Novo Ventures Co-leads US$83m Series C Financing in Lava Therapeutics". Copenhagen. |
2020-09-17 |
Amadeus Capital Partners. (9/15/20). "Press Release: Amadeus Appoints New Partners Edward Kliphuis and Kai Schmitz". London & Bogotá. |
2020-09-15 |
Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX. |
2020-09-15 |
Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". |
2020-09-14 |
Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam. |
2020-09-14 |
Gilead Sciences, Inc.. (9/13/20). "Press Release: Gilead Sciences to Acquire Immunomedics". Foster City, CA & Morris Plains, NJ. |
2020-09-13 |
Atbtherapeutics. (9/9/20). "Press Release: Atbtherapeutics Appoints Dr Werner Cautreels and Dr Vincent Brichard to Its Board of Directors to Foster Development of Its Game-changing Antibody-toxin Bioengineered ‘Atbody’ Therapeutics". Belgium. |
2020-09-09 |
Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven. |
2020-09-08 |
IcanoMab GmbH. (9/7/20). "Press Release: IcanoMab GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19". Polling. |
2020-09-07 |
Scope Fluidics S.A.. (9/7/20). "Press Release: Poland – EIB Lends up to EUR 10 Million to Scope Fluidics to Develop Diagnostics Dquipment for Infectious Diseases". Luxembourg & Warsaw. |
2020-09-07 |
CMS. (9/7/20). "Pressemitteilung: CMS begleitet Gründer des KI Start-ups Semalytix bei Serie-A Finanzierungsrunde". Berlin. |
2020-09-07 |
Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. |
2020-09-07 |
Imcyse S.A.. (9/7/20). "Press Release: Imcyse Announces the Appointment of Denis Bedoret as Chief Executive Officer". Liège. |
2020-09-07 |
EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". |
2020-09-03 |
Amarna Therapeutics B.V.. (9/3/20). "Press Release: Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer". Leiden. |
2020-09-03 |
IME Medical Electrospinning. (9/3/20). "Press Release: IME Medical Electrospinning Secured € 3 Million in New Financing From Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and From Rabobank to Further Expand its Medispin XL Production Platform". Waal |
2020-09-03 |
Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London. |
2020-09-01 |
Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". |
2020-08-31 |
Royal Philips. (8/27/20). "Press Release: Philips to Expand Its Image-guided Therapy Devices Portfolio through Acquisition of Intact Vascular". Amsterdam. |
2020-08-27 |
NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden. |
2020-08-25 |
Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen. |
2020-08-19 |
MLM Medical Labs GmbH. (8/19/20). "Press Release: MLM Medical Labs Appoints Isabel Struik as VP Sales & Marketing". Düsseldorf. |
2020-08-19 |
Byondis B.V.. (8/19/20). "Press Release: Byondis Announces Appointment of Chief Financial Officer". Nijmegen. |
2020-08-19 |
CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-18 |
Exscientia Ltd.. (8/18/20). "Press Release: Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats". Brussels. |
2020-08-18 |
CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-14 |
Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. |
2020-08-13 |
Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. |
2020-08-12 |
Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. |
2020-08-11 |
Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen. |
2020-08-11 |
CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. |
2020-08-10 |
Dyne Therapeutics Inc.. (8/10/20). "Press Release: Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases". Waltham, MA. |
2020-08-10 |
Bruker Corporation. (8/7/20). "Press Release: Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry". Billerica, MA. |
2020-08-07 |
Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. |
2020-08-05 |
CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. |
2020-08-04 |
Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. |
2020-07-30 |
Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. |
2020-07-29 |
DNA Script. (7/29/20). "Press Release: DNA Script Expands Series B to $89M". Paris & South San Francisco, CA. |
2020-07-29 |
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. |
2020-07-28 |
iTeos Therapeutics Inc.. (7/23/20). "Press Release: iTeos Therapeutics Announces Pricing of Initial Public Offering". Cambridge, MA & Gosselies. |
2020-07-23 |
Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. |
2020-07-21 |
Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. |
2020-07-16 |
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. |
2020-07-14 |
Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. |
2020-07-13 |
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. |
2020-07-09 |
Belgian Growth Fund. (7/9/20). "Press Release: Final Closing Belgian Growth Fund at 312 Million Euro". |
2020-07-09 |
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. |
2020-07-09 |
OncoDNA S.A.. (7/9/20). "Press Release: Agreement to File a Friendly Takeover Bid Initiated by OncoDNA on IntegraGen to Acquire All Outstanding Shares at a Price of 2.20€ per Share". Gosselies & Evry. |
2020-07-09 |
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. |
2020-07-08 |
Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. |
2020-07-08 |
CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN. |
2020-07-07 |
Molecular Partners AG. (7/7/20). "Press Release: Molecular Partners Successfully Completes Private Placement of 5,528,089 Shares by Way of an Accelerated Bookbuilding". Zürich-Schlieren. |
2020-07-07 |
Excelya S.A.S.. (7/6/20). "Press Release: Excelya Welcomes Three European Contract Research Organizations to Become One Stop Provider Throughout Europe". Boulogne-Billancourt. |
2020-07-06 |
CureVac AG. (7/6/20). "Press Release: EIB and European Commission Provide CureVac with a €75 Million Financing for Vaccine development and Expansion of Manufacturing". |
2020-07-06 |
Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. |
2020-07-02 |
S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. |
2020-07-02 |
Citryll B.V.. (7/2/20). "Press Release: Citryll Completes € 18.5 M Fundraise to Develop CIT-013, an Antibody Targeting Neutrophil Extracellular Traps". Oss. |
2020-07-02 |